ABOUT SIRPIGLENASTAT CLINICAL TRIAL

“This specific prodrug structure built DON qualified to its meant vacation spot (tumor) and have considerably less of the influence on healthy cells in other places.”It's anticancer effects by directly concentrating on tumor metabolism and concurrently inducing a strong antitumor immune response with immunomodulatory and antineoplastic actions.